Joshua Wells - CryoLife Sr Devel

CYL Stock  EUR 27.20  0.20  0.74%   

Insider

Joshua Wells is Sr Devel of CryoLife
Phone770 419 3355
Webhttps://artivion.com

CryoLife Management Efficiency

The company has return on total asset (ROA) of 0.0122 % which means that it generated a profit of $0.0122 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0656) %, meaning that it generated substantial loss on money invested by shareholders. CryoLife's management efficiency ratios could be used to measure how well CryoLife manages its routine affairs as well as how well it operates its assets and liabilities.
CryoLife has accumulated 306.5 M in total debt with debt to equity ratio (D/E) of 98.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CryoLife has a current ratio of 4.93, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist CryoLife until it has trouble settling it off, either with new capital or with free cash flow. So, CryoLife's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CryoLife sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CryoLife to invest in growth at high rates of return. When we think about CryoLife's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Xu ZhaoChina Communications Services
48
Julie LodgeJarrettDICKS Sporting Goods
47
Vladimir RakDICKS Sporting Goods
46
Raymond KummerCogent Communications Holdings
74
Ried ZulagerCogent Communications Holdings
N/A
Hongzhi LiangChina Communications Services
47
David SchaefferCogent Communications Holdings
67
Fin FCCAChina Communications Services
48
Naz SarkarComputershare Limited
N/A
Peter LandDICKS Sporting Goods
N/A
Yonghe YangChina Communications Services
N/A
Nick OldfieldComputershare Limited
N/A
Timothy ONeillCogent Communications Holdings
67
Lauren HobartDICKS Sporting Goods
55
JeanMichel SlagmuylderCogent Communications Holdings
60
Mark McDougallComputershare Limited
N/A
Vincent CornoDICKS Sporting Goods
59
Hiroshi EtoFukuyama Transporting Co
60
Fiona ChalmersComputershare Limited
N/A
Xiaoqing HuangChina Communications Services
58
Hiroshi YamamotoFukuyama Transporting Co
N/A
CryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia. CRYOLIFE INC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1100 people. CryoLife (CYL) is traded on Frankfurt Exchange in Germany and employs 1,300 people.

Management Performance

CryoLife Leadership Team

Elected by the shareholders, the CryoLife's board of directors comprises two types of representatives: CryoLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CryoLife. The board's role is to monitor CryoLife's management team and ensure that shareholders' interests are well served. CryoLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CryoLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
CPA CPA, VP Officer
James Mackin, Pres Chairman
Dennis Maier, VP Operations
Joshua Wells, Sr Devel
Marshall MD, VP Officer
Jean Esq, Gen VP
John Davis, VP Marketing
Matthew Getz, VP HR

CryoLife Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CryoLife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in CryoLife Stock

CryoLife financial ratios help investors to determine whether CryoLife Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CryoLife with respect to the benefits of owning CryoLife security.